Cabometyx (cabozantinib) — Medica
Gastrointestinal stromal tumor
Initial criteria
- age ≥ 18 years
- patient has tried all of the following: (1) imatinib or avapritinib, (2) sunitinib or dasatinib, (3) regorafenib, and (4) ripretinib
Approval duration
1 year